LOS ANGELES--(BUSINESS WIRE)--Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, today announced that Carlo Montagner, president of the Abraxis Oncology division, will present a company overview at the Lazard Capital Markets Life Sciences Conference on Tuesday, November 28, 2006 at 11:00 a.m. EST at the New York Palace in New York City.
